Skip to main content
. 2021 Nov 26;2021:2135942. doi: 10.1155/2021/2135942

Table 3.

Comparison of the parameters between different risk groups.

Parameters Low risk (n = 7) Intermediate risk (n = 7) High risk (n = 3) P value△
sPAP (mmHg) 32.0 ± 8.0 59.8 ± 31.2 61.5 ± 9.2 0.23
TAPSE (cm) 2.7 ± 0.1 2.1 ± 0.4 1.4 ± 0.3 0.012∗
RAP (mmHg) 5.8 ± 1.5 8.2 ± 3.7 15 ± 0 0.147
NT-proBNP (pg/mL) 247.8 ± 250.1 1456.5 ± 719.8 5418.5 ± 2617 0.003∗
SUA (ummol/L) 430.8 ± 117.9 436.7 ± 92.3 518.5 ± 89.8 0.67
RDW (%) 15.4 ± 2.3 21.7 ± 10.2 18.5 ± 1.7 0.315
VD (n/mm2) 2.7 ± 0.3 2.3 ± 0.2 1.7 ± 0.4 0.006∗
MFI 2.8 ± 0.4 2.3 ± 0.3 1.5 ± 0.7 0.019∗
Conjunctival microvascular changes graphic file with name DM2021-2135942.tab3.i001.jpg graphic file with name DM2021-2135942.tab3.i002.jpg graphic file with name DM2021-2135942.tab3.i003.jpg

sPAP: systolic pulmonary artery pressure; TAPSE: tricuspid annular plane systolic excursion; RAP: right atrial pressure; NT-proBNP: N-terminal prohormone of brain natriuretic peptide; SUA: serum uric acid; RDW: red blood cell volume distribution width; VD: vessel density; MFI: microvascular flow index. ∗P < 0.05. △ Kruscal-Wallis test; # ischemic areas; ⟶ microangioma.